Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Dec;93(12):4774-9.
doi: 10.1210/jc.2008-0772. Epub 2008 Sep 30.

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions

Affiliations
Randomized Controlled Trial

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions

Robert E Ratner et al. J Clin Endocrinol Metab. 2008 Dec.

Abstract

Context: A past history of gestational diabetes mellitus (GDM) confers a very high risk of postpartum development of diabetes, particularly type 2 diabetes.

Objective: The Diabetes Prevention Program (DPP) sought to identify individuals with impaired glucose tolerance (IGT) and intervene in an effort to prevent or delay their progression to diabetes. This analysis examined the differences between women enrolled in DPP with and without a reported history of GDM.

Design: The DPP was a randomized, controlled clinical trial.

Setting: The study was a multicenter, National Institutes of Health-sponsored trial carried out at 27 centers including academic and Indian Health Services sites.

Patients: A total of 2190 women were randomized into the DPP and provided information for past history of GDM. This analysis addressed the differences between those 350 women providing a past history of GDM and those 1416 women with a previous live birth but no history of GDM.

Interventions: Subjects were randomized to either standard lifestyle and placebo or metformin therapy or to an intensive lifestyle intervention.

Main outcomes: The primary outcome was the time to development of diabetes ascertained by semiannual fasting plasma glucose and annual oral glucose tolerance testing. Assessments of insulin secretion and insulin sensitivity were also performed.

Results: Whereas entering the study with similar glucose levels, women with a history of GDM randomized to placebo had a crude incidence rate of diabetes 71% higher than that of women without such a history. Among women reporting a history of GDM, both intensive lifestyle and metformin therapy reduced the incidence of diabetes by approximately 50% compared with the placebo group, whereas this reduction was 49 and 14%, respectively in parous women without GDM. These data suggest that metformin may be more effective in women with a GDM history as compared with those without.

Conclusions: Progression to diabetes is more common in women with a history of GDM compared with those without GDM history despite equivalent degrees of IGT at baseline. Both intensive lifestyle and metformin are highly effective in delaying or preventing diabetes in women with IGT and a history of GDM.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ethnic representation of parous women with and without a history of GDM randomized into the DPP.
Figure 2
Figure 2
Cumulative incidence of diabetes mellitus among the placebo group by history of GDM.
Figure 3
Figure 3
Change in weight during DPP by randomized treatment group. Panel A, Women without a history of GDM; Panel B, women with a history of GDM.
Figure 4
Figure 4
Cumulative incidence of diabetes in DPP by randomized treatment group. Panel A, Women without a history of GDM; Panel B, women with a history of GDM.

Comment in

References

    1. O'Sullivan JB, Mahan CM 1964 Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13:278–285 - PubMed
    1. O'Sullivan JB 1991 Diabetes mellitus after GDM. Diabetes 40(Suppl 2):131–135 - PubMed
    1. The Diabetes Prevention Program Research Group 1999 The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes mellitus. Diabetes Care 22:623–634 - PMC - PubMed
    1. The Diabetes Prevention Program Research Group 2000 The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care 23:1619–1629 - PMC - PubMed
    1. The Diabetes Prevention Program Research Group 2002 The Diabetes Prevention Program: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403 - PMC - PubMed

Publication types